Arctic Bioscience investor converts debt to shares

Arctic Bioscience announced that an investor participating in the NOK 15 million convertible loan consortium has converted NOK 270,365 of outstanding debt into shares. The conversion amount includes accrued interest, and the conversion price was set at NOK 2.7896 per share. This action follows the convertible loan financing announced on January 13, 2025.

The board will issue new shares in accordance with the authorization granted by the company's general assembly on May 26, 2025. Following this capital increase, Arctic Bioscience will have a total of 26,956,257 shares issued.